Phibro Animal Health Corporation Class A (PAHC)
Phibro Animal Health Corporation Class A (PAHC) is a global provider of innovative solutions, including vaccines, medicines, mineral feed additives, and other products aimed at improving the health and performance of animals. Founded in 1946, the company serves the livestock, poultry, and aquaculture industries with a focus on sustainability and advancing animal well-being through a broad portfolio of pharmaceutical and nutritional products.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 24, 2025 | $0.12 | 2025-09-03 | 2025-09-03 |
| June 25, 2025 | $0.12 | 2025-06-04 | 2025-06-04 |
| March 26, 2025 | $0.12 | 2025-03-05 | 2025-03-05 |
| December 18, 2024 | $0.12 | 2024-11-27 | 2024-11-27 |
| September 25, 2024 | $0.12 | 2024-09-04 | 2024-09-04 |
Dividends Summary
- Phibro Animal Health Corporation Class A has issued 45 dividend payments over the past 11 years
- The most recent dividend was paid 28 days ago, on September 24, 2025
- The highest dividend payed out to investors during this period was $0.12 per share
- The average dividend paid during this period was $0.11 per share.
Company News
Phibro Animal Health reported strong Q4 FY2025 earnings, with 39% revenue growth driven by the Zoetis medicated feed additive acquisition. Despite robust sales and adjusted EBITDA, gross margins declined due to higher distribution costs and product mix challenges.
The article recommends two value stocks to buy for February 14th: Adtalem Global Education (ATGE) and Phibro Animal Health (PAHC). Both companies have a Zacks Rank #1 and have seen their earnings estimates increase in the last 60 days, indicating positive sentiment.
The poultry pharmaceuticals market is dominated by vaccines due to rising concerns over infectious diseases and regulatory restrictions on antibiotics. The market is projected to reach $6.68 billion by 2029, driven by increasing poultry consumption and the need for effective disease management.
Phibro Animal Health Corporation's robust sales of vaccines and medicated feed additives (MFAs) are driving growth in its Animal Health business. The company's focus on advancing nutritional specialties and vaccine technologies, along with a new vaccine production unit, instills optimism. However, adverse macroeconomic impacts and growing competi...